Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2014
05/01/2014WO2014063199A1 Organic compounds
05/01/2014WO2014063193A1 Substituted sulfone-containing tricyclic compounds and uses thereof
05/01/2014WO2014063190A1 Method for reducing triglycerides
05/01/2014WO2014063189A1 Methods and products for preventing and/or treating a stress induced cardiomyopathy
05/01/2014WO2014047393A9 N-substituted bis(fluoroalkyl)-1,4-benzodiazepinone compounds
05/01/2014WO2014037834A3 Compositions and methods for treatment of inflammation and lipid disorders
05/01/2014WO2014037832A3 Compositions and methods for treatment of epilepsy and neurological diseases
05/01/2014WO2014037416A3 Compositions for treating parkinson's disease
05/01/2014WO2014036314A3 Diagnosis of rheumatoid arthritis (ra) using differentially methylated loci identified in peripheral blood mononuclear cells, t-cells, b-cells and monocytes
05/01/2014WO2014035140A3 Compounds and compositions for modulating histone methyltransferase activity
05/01/2014WO2014033744A3 A novel pharmaceutical composition of linezolid
05/01/2014WO2014033668A3 Combination of a macrocyclic protease inhibitor of hcv, a non-nucleoside hcv inhibitor and ritonavir
05/01/2014WO2014030132A3 Statins for periodontal disease and bone regeneration
05/01/2014WO2014028597A3 3-CYCLOHEXENYL AND CYCLOHEXYL SUBSTITUTED INDOLE AND INDAZOLE COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF
05/01/2014WO2014024013A8 Pseudouridimycin (pum) and its derivates
05/01/2014WO2014018563A3 Methods for the treatment of cancer
05/01/2014WO2014005010A3 Methods of treating breast cancer with gemcitabine therapy
05/01/2014WO2014004572A3 Modulation of ube3a-ats expression
05/01/2014WO2013185764A3 Pharmaceutical compositions for combination therapy
05/01/2014WO2013158145A9 Methods of therapeutic monitoring of phenylacetic acid prodrugs
05/01/2014WO2013149121A8 1,3,4-OXADIAZOLE AND 1,3,4-THIADIAZOLE β-LACTAMASE INHIBITORS
05/01/2014WO2013137912A3 Methods of distributing complement-inhibiting drugs to patients receiving a complement inhibitor
05/01/2014WO2013122575A3 Small molecule having antiviral properties
05/01/2014WO2013075084A8 Modulators of methyl modifying enzymes, compositions and uses thereof
05/01/2014WO2013068565A3 Melatonin-based solutions and powders for their preparation
05/01/2014WO2013036286A3 Retinal cyclodextrin acetals and hemiacetals for clarifying skin complexion
05/01/2014WO2013016621A3 Method for the treatment of addiction to tobacco
05/01/2014WO2013009885A3 Evaluation of copolymer diethylamide
05/01/2014WO2013003037A3 Anti-erbb3 antibodies in combination with paclitaxel for treatment of gynecological cancers
05/01/2014WO2012174158A3 Administration of benzodiazepine
05/01/2014WO2012170827A3 Pyrazolopyrimidines and related heterocycles as ck2 inhibitors
05/01/2014WO2012167226A3 Method, composition, and articles for improving joint lubrication
05/01/2014WO2012158550A3 Selective heterocyclic sphingosine 1 phosphate receptor modulators
05/01/2014WO2012149097A3 Guanidylimidazole and guanidylimidazoline derivatives as antimalarial agents, synthesis of and methods of use thereof
05/01/2014WO2012145112A3 Novel maytansinoid derivatives with sulfoxide linker
05/01/2014WO2012142302A3 Biocatalytic process for preparing eslicarbazepine and analogs thereof
05/01/2014WO2012139019A3 New indolinone protein kinase inhibitors
05/01/2014WO2012138907A3 Solid forms of curcumin
05/01/2014WO2012135465A3 Treatment of glaucoma
05/01/2014WO2012135113A3 Cyclopropylamines as lsd1 inhibitors
05/01/2014WO2012134971A3 Opsin-binding ligands, compositions and methods of use
05/01/2014WO2012125791A3 Incorporation of the b18r gene to enhance antitumor effect of virotherapy
05/01/2014WO2012125663A3 Cyclohexane substituted amino cyclopentane derivatives as useful ccr2 antagonists
05/01/2014WO2012125554A3 Compositions and methods for the treatment of cancer
05/01/2014WO2012125402A3 Dosing regimens for the treatment of fabry disease
05/01/2014WO2012122542A3 Intelligent airfoil component surface imaging inspection
05/01/2014WO2012112623A3 Rxrg modulators for the treatment of cancer
05/01/2014US20140121732 Methods and compositions for administering a specific wavelength phototherapy
05/01/2014US20140121646 Nutrient Absorption Barrier And Delivery Method
05/01/2014US20140121611 Compositions and methods for transdermal delivery of amphetamine
05/01/2014US20140121318 Emulsified compositions comprising crosslinked polymers containing biomass derived materials
05/01/2014US20140121284 Stable Pharmaceutical Composition
05/01/2014US20140121283 Methods of using derivatives of (-)-venlafaxine
05/01/2014US20140121279 Enkephalin Analogues
05/01/2014US20140121278 Anti-tumor agent otx-008 targets human galectin-1
05/01/2014US20140121277 Use of methionine sulfoximine to treat acute liver failure and other diseases caused by an inflammatory cytokine response
05/01/2014US20140121276 Method for alleviating fear memory
05/01/2014US20140121275 Method of Feeding Livestock to Improve Carcass Characteristics
05/01/2014US20140121273 Method for treatment of magnesium and potassium deficiencies
05/01/2014US20140121270 Formulations and methods to provide nutrition to human and other patients
05/01/2014US20140121266 Choline Esters
05/01/2014US20140121264 MICRORNA (miRNA) AND DOWNSTREAM TARGETS FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES
05/01/2014US20140121257 Alpha-1-adrenergic receptor agonist therapy
05/01/2014US20140121256 Method of treating muscular weakness comprising administering a composition comprising an effective amount of histamine and/or serotonin
05/01/2014US20140121255 Methods of Treating Psoriasis Using Allantoin
05/01/2014US20140121254 Pharmaceutical compositions for the treatment of movement disorders
05/01/2014US20140121248 Metalloenzyme inhibitor compounds
05/01/2014US20140121247 Methods for Controlling Blood Pressure and Reducing Dyspnea in Heart Failure
05/01/2014US20140121237 Methods for Inhibiting Virus Replication
05/01/2014US20140121235 Method for Treating S6K-Overexpressing Cancers
05/01/2014US20140121234 Inhalant propellant-free aerosol formulation
05/01/2014US20140121232 Abuse-deterrent drug formulations
05/01/2014US20140121229 Combination comprising s-[2-([[1-(2-ethylbutyl)cyclohexyl] carbonyl]amino)phenyl] 2-methylpropanethioate and an hmg coa reductase inhibitor
05/01/2014US20140121228 Quinazoline Derivatives as VEGF Inhibitors
05/01/2014US20140121227 Therapeutic treatment
05/01/2014US20140121225 Polymorph of linagliptin benzoate
05/01/2014US20140121224 Quinazolinones as inhibitors of human phosphatidyositol 3-kinase delta
05/01/2014US20140121223 Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
05/01/2014US20140121218 Method for treating ocular cancer
05/01/2014US20140121215 Process for the preparation of amorphous imatinib mesylate
05/01/2014US20140121211 Thiol mediated/activated prodrugs of sulfur dioxide (so2) having anti-bacterial activity
05/01/2014US20140121209 Compositions & methods for lowering intraocular pressure
05/01/2014US20140121208 Compositions for Treatment of Cystic Fibrosis and Other Chronic Diseases
05/01/2014US20140121204 Novel dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders.
05/01/2014US20140121202 S-t-BUTYL PROTECTED CYSTEINE DI-PEPTIDE ANALOGS AND RELATED COMPOUNDS
05/01/2014US20140121201 REGULATORY NETWORK FOR Th17 SPECIFICATION AND USES THEREOF
05/01/2014US20140121199 (THIENO[2,3-b][1,5]BENZOXAZEPIN-4-YL)PIPERAZIN-1-YL COMPOUNDS AS DUAL ACTIVITY H1 INVERSE AGONISTS/5-HT2A ANTAGONISTS
05/01/2014US20140121193 Methods for treating fibromyalgia
05/01/2014US20140121191 Oral Energy Supplement and Related Methods
05/01/2014US20140121190 Use of 3-alpha-androstanediol, optionally in combination with a pde5 inhibitor, in the treatment of sexual dysfunction
05/01/2014US20140121189 Use of 3-alpha-androstanediol, optionally in combination with a 5-ht1a agonist, in the treatment of sexual dysfunction
05/01/2014US20140121188 Compositions for the improved treatment of acne and related disorders
05/01/2014US20140121185 Compounds and compositions for use in the treatment and prevention of cancer and precancerous conditions, inflammation-related disorders, pain and fever
05/01/2014US20140121180 Sucrose octasulfates of magnesium, preparation method thereof and pharmaceutical cosmetic uses of same
05/01/2014US20140121178 Method and improved pharmaceutical composition for improving the absorption of an ester prodrug
05/01/2014US20140121177 Soyasapogenol composition
05/01/2014US20140121176 Topical wash composition for use in acne patients
05/01/2014US20140121175 Antitumor agent
05/01/2014US20140121173 Systems and methods to estimate nutritional needs of human and other patients
05/01/2014US20140121172 Formulations containing labels for medical diagnostics
1 ... 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 ... 7860